Parsalmide
Parsalmide is an orally active non-steroidal anti-inflammatory drug and gastroprotective agent, with an IC50 of 9.92 μM against COX-1 and 155 μM against COX-2. Parsalmide prevents gastric injury and reduces edema. Parsalmide can be used in the research of arthritis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 30653-83-9
- Formule: C14H18N2O2
- Masse moléculaire:246.31
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
Ovine COX-1 9.92 μM (IC50) |
Ovine COX-2 155 μM (IC50) |
Parsalmide (0.01 nM-0.1 mM; 45 min) potently inhibits purified ovine COX-1 with an IC50 of 9.92 μM, and also inhibits purified ovine COX-2 with an IC50 of 155 μM, showing a 16-fold higher selectivity for COX-1 over COX-2[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parsalmide (100 mg/kg; p.o.; single administration) does not induce acute gastric injury in rats at its effective anti-inflammatory dose of 100 mg/kg[1].
Parsalmide (100 mg/kg; p.o.; single administration) significantly prevents indomethacin (HY-14397)-induced gastric injury in rats[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Wistar rats treated Carrageenin (male, 120-140 g)[1]
-
Dosage:10 mg/kg; 100 mg/kg
-
Administration:p.o.; single dose
-
Result:Inhibited paw edema formation by 9% at 10 mg/kg.
Inhibited paw edema formation by 83% at 100 mg/kg.
Exhibited an ED50 of 82 mg/kg for anti-inflammatory activity.
-
Animal Model:Wistar rats treated Indomethacin (male, 120-140 g)[1]
-
Dosage:100 mg/kg
-
Administration:p.o.; single dose; administered 1 hour before indomethacin
-
Result:Significantly reduced indomethacin-induced gastric damage, with a gastric damage score markedly lower than the vehicle-treated control group.
Chemical Information
-
CAS No. 30653-83-9
-
Masse moléculaire 246.31
-
Formule C14H18N2O2
-
SMILES
O=C(NCCCC)C1=CC(N)=CC=C1OCC#C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Parsalmide Related Classifications
HY-127145 Related Classifications
Powered by Bioz